Long-term outcomes after a randomized phase II trial of nerve growth factor eye drops for optic pathway gliomas: four-year follow-up findings in children.
- DOI
- 10.1007/s11060-026-05777-z
- Published
- 2026 Sep 1
- Container
- Journal of neuro-oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s11060-026-05777-z,
title = {Long-term outcomes after a randomized phase II trial of nerve growth factor eye drops for optic pathway gliomas: four-year follow-up findings in children.},
author = {Ruggiero A and Attinà G and Placidi G and D'Agostino E and Amato A and Verdolotti T and Mastrangelo S and Falsini B},
year = {2026},
journal = {Journal of neuro-oncology},
doi = {10.1007/s11060-026-05777-z},
url = {https://doi.org/10.1007/s11060-026-05777-z}
}RIS
TY - JOUR TI - Long-term outcomes after a randomized phase II trial of nerve growth factor eye drops for optic pathway gliomas: four-year follow-up findings in children. AU - Ruggiero A AU - Attinà G AU - Placidi G AU - D'Agostino E AU - Amato A AU - Verdolotti T AU - Mastrangelo S AU - Falsini B PY - 2026 JO - Journal of neuro-oncology DO - 10.1007/s11060-026-05777-z UR - https://doi.org/10.1007/s11060-026-05777-z ER -
APA
A, R., G, A., G, P., E, D., A, A., T, V., S, M., & B, F. (2026). Long-term outcomes after a randomized phase II trial of nerve growth factor eye drops for optic pathway gliomas: four-year follow-up findings in children.. Journal of neuro-oncology. https://doi.org/10.1007/s11060-026-05777-z
Source records
- pubmed · retrieved 2026-09-25T21:28:46.304Z